These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1283526)

  • 1. Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative alpha-helical region.
    Poumbourios P; McPhee DA; Kemp BE
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2055-62. PubMed ID: 1283526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence.
    Poumbourios P; Wilson KA; Center RJ; El Ahmar W; Kemp BE
    J Virol; 1997 Mar; 71(3):2041-9. PubMed ID: 9032336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
    Poumbourios P; el Ahmar W; McPhee DA; Kemp BE
    J Virol; 1995 Feb; 69(2):1209-18. PubMed ID: 7815497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
    J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.
    Jiang S; Lin K; Lu M
    J Virol; 1998 Dec; 72(12):10213-7. PubMed ID: 9811763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenetic properties of peptides mimicking a human immunodeficiency virus gp41 (HIV-1) epitope recognized by virus-neutralizing antibody 2F5].
    Tumanova OIu; Kuvshinov VN; Orlovskaia IA; Proniaeva TR; Pokrovskiĭ AG; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2003; 37(3):556-60. PubMed ID: 12815965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies.
    Yuan W; Li X; Kasterka M; Gorny MK; Zolla-Pazner S; Sodroski J
    AIDS Res Hum Retroviruses; 2009 Mar; 25(3):319-28. PubMed ID: 19292593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
    Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.
    Veronese FD; Rahman R; Kalyanaraman VS; Pal R; Lusso P; Tritch R; Petteway S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):479-86. PubMed ID: 2480151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
    Earl PL; Broder CC; Doms RW; Moss B
    J Virol; 1997 Apr; 71(4):2674-84. PubMed ID: 9060620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
    Menendez A; Chow KC; Pan OC; Scott JK
    J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of anti-gp41 core structure antibodies, which compete with sera of HIV-1-infected patients.
    Usami O; Xiao P; Ling H; Liu Y; Nakasone T; Hattori T
    Microbes Infect; 2005 Apr; 7(4):650-7. PubMed ID: 15823513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
    Cleveland SM; Jones TD; Dimmock NJ
    J Gen Virol; 2000 May; 81(Pt 5):1251-60. PubMed ID: 10769067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1.
    McLain L; Brown JL; Cheung L; Reading SA; Parry C; Jones TD; Cleveland SM; Dimmock NJ
    Arch Virol; 2001; 146(1):157-66. PubMed ID: 11266210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.
    de Haard JJ; Kazemier B; Oudshoorn P; Boender P; van Gemen B; Koolen MJ; van der Groen G; Hoogenboom HR; Arends JW
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():2883-94. PubMed ID: 9880001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
    Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.